Fusion Pharmaceuticals Inc (FUSN) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fusion Pharmaceuticals Inc   (NASDAQ: FUSN)


Fusion Pharmaceuticals Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fusion Pharmaceuticals Inc's ROI in the first quarter of 2024?
Fusion Pharmaceuticals Inc recorded a cumulative net loss of $-104 million during 12 months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -38.8%.

Within the Healthcare sector 484 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 0 to 3687.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM 20.15 % 17.47 % 5.58 % -0.57 % -9.71 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 303 270 251 251 249
Return On Investment (TTM) -38.8 % -37.17 % -38.23 % -42.21 % -41.12 %
FUSN's Overall Ranking # 3687 # 0 # 131 # 59 # 131
Seq. Investment Change TTM 5.27 % 6.87 % 2.82 % 3.87 % 2.93 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -104 -95 -91 -98 -92

FUSN Company Profile >> Back to FUSN Roi Comparisons >> See Annual FUSN Return On Investment



Return On Investment FUSN's Ranking
Within: No.
Industry # 65
Sector # 485
Overall # 3687

Return On Investment Statistics
High Average Low
40.25 %
-9.18 %
-56.71 %
(Dec 31 2022)   (Jun 30 2020)







Financial Statements
Fusion Pharmaceuticals Inc's I. Quarter Investments $ 303 Millions FUSN's Balance sheet
Fusion Pharmaceuticals Inc's I. Quarter Income $ -34 Millions Quarterly FUSN's Income Statement
FUSN's Income by Division See FUSN's Income by Division


FUSN Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 270 204 240 296 0
Y / Y Investment Growth 32.17 % -14.92 % -18.95 % - -
Net Income in Millions -95 88 -81 -78 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -35.2 % 42.95 % -33.8 % -26.48 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FUSN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FUSN's Competitors
Subscribers only: Roi for Fusion Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for FUSN's Customers

Other Ratios
FUSN's Roa FUSN's Inventory Turnover Ratio FUSN's Growth Rates FUSN's Dividend Statistics
FUSN's Profitability Ratios FUSN's Asset Turnover Ratio FUSN's Dividend Growth
FUSN's Roe FUSN's Valuation Ratios FUSN's Financial Strength Ratios FUSN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-08T15:22:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.